Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Veracyte, Inc. today announced the launch of Screen Together (www.ScreenTogether.com), an awareness campaign aimed at increasing routine screening...
Veracyte, Inc. (NASDAQ: VCYT) announced today that results of a study supporting the early development of the Envisia Genomic Classifier have been...
Veracyte, Inc. (NASDAQ: VCYT) announced today that it has been awarded a 2017 Top Workplaces honor by the Bay Area News Group. This marks the fourth...
Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the William Blair 2017...
Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...
Revenue was $16.4 Million, a 21% Growth Over Prior Year Cash Burn was $8.3 Million, a 28% Improvement Over Prior Year Conference Call and Webcast...
Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its first quarter 2017 financial results after close of market on Wednesday, May 3, ...
Revenue Grew 31%, to $65.1 Million in 2016 Full-Year Afirma® GEC Volume Increased 20%, to 23,237 Tests Conference Call and Webcast Today at 4:30 p.m. ...
Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its fourth quarter and full-year 2016 financial results after close of market on...
Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman of the board, president and chief executive officer, will present at...
Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...
Veracyte, Inc. (NASDAQ: VCYT) announced today that the Centers for Medicare and Medicaid Services (CMS) has released its revised final 2017 Medicare...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.